Stereotactic Body Radiation Therapy and FES PET/CT Imaging for Breast Cancer
Phase 2
18
about 2.3 years
18+
2 sites in CA
What this study is about
Researchers are testing whether stereotactic body radiation therapy (SBRT) can be used to treat estrogen receptor-positive breast cancer that has spread. The trial also tests if a special imaging technique, FES PET/CT, can help identify when the cancer progresses in these patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Questionnaire Administration
- 2.Receive Stereotactic Body Radiation Therapy
- 3.Take F-18 16 Alpha-Fluoroestradiol
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Positron Emitting Activity
Secondary: Change in quality of life (QOL), Progression free survival (PFS)
diagnostic, imaging, radiation
Oncology